S&P 500: 682.77 -1.3% NASDAQ 100: 601.73 -1.9% Dow Jones: 496.00 -1.1%

Thermo Fisher Scientific Inc.

TMO Healthcare
$509.37 $-17.8 (-3.38%)
Market Cap: $191.37 B
Gurus Holding
20
Popularity Rank
#29
% of Shares Held
2.08%
Net Activity (Q3 2025)
+$379.77 M

Guru Ownership Trend

Guru Analysis for Thermo Fisher Scientific Inc. (TMO)

Thermo Fisher Scientific Inc. (TMO), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 20 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.98 B.

Top institutional holders include Ken Fisher and Jeremy Grantham.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $379.77 M net inflow during the quarter.

Recent activity highlights Larry Robbins who increased their stake by 182.9%. Conversely, Manning & Napier Group reduced exposure by 97.8%.

Key Holders

Top 5 by Value

$1.62 B
$1.04 B
$623.21 M
$137.23 M

Top 5 by Conviction

Recent Activity Breakdown (Q3 2025)

+$718.27 M
Total Buy Value
New Buys 3
Additions 8
-$338.51 M
Total Sell Value
Reductions 5
Sold Out 3

Guru Consensus (Q3 2025)

Based on recent activity
Net Sellers
8
Net Buyers
11

FAQs for Thermo Fisher Scientific Inc. (TMO)

Major holders include Ken Fisher ($1.62 B), Jeremy Grantham ($1.04 B), Al Gore ($623.21 M). According to the latest reported data, 20 tracked investment managers collectively hold approximately 7.81 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $379.77 M, with 11 managers increasing positions and 8 managers reducing holdings.

During the most recent reporting period, 5 managers trimmed their positions, while 3 fully exited TMO. The total reported sell value was $338.51 M.

Yes, 3 managers opened new positions in TMO, and 8 increased their existing holdings. The total reported buy value was $718.27 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.55% Add 2.6% 2,792,421 $1.62 B Q4 2025
2.93% Add 15.7% 2,141,863 $1.04 B Q3 2025
4.13% Add 29.9% 1,284,924 $623.21 M Q3 2025
1.37% Reduce -7.9% 460,301 $266.72 M Q4 2025
3.05% Add 182.9% 282,941 $137.23 M Q3 2025
1.44% Add 146.0% 214,946 $104.25 M Q3 2025
0.14% Reduce -54.4% 169,451 $82.19 M Q3 2025
4.64% Reduce -10.3% 134,950 $78.2 M Q4 2025
0.05% Add 43.2% 155,608 $72.43 M Q3 2025
0.29% Add 12.5% 62,800 $36.39 M Q4 2025
0.15% Reduce -10.0% 71,776 $34.81 M Q3 2025
1.74% Add 0.6% 14,295 $6.93 M Q3 2025
0.05% Reduce -97.8% 6,384 $3.72 M Q4 2025
0.76% Reduce -20.0% 6,400 $3.71 M Q4 2025
0.03% Reduce -9.5% 4,646 $2.69 M Q4 2025
0.00% Add 70.2% 1,450 $839,997 Q4 2025
0.01% 1,616 $783,792 Q3 2025
0.06% 1,396 $677,088 Q3 2025
0.23% New Buy 820 $397,716 Q3 2025
0.00% 438 $253,799 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form